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A novel technique designed to minimize the
morbidity of failure of arteriovenous access in
hemodialysis patients
Bernard J. Benedetto, MD, Robert L. Madden, MD, Alexander Kurbanov, MD, and
George S. Lipkowitz, MD, Springfield, Mass
The failure of dialysis access grafts leads to significant morbidity rates in patients with end-stage renal disease. We describe
a novel technique for the insertion of new polytetrafluoroethylene graft segments designed to reduce this morbidity rate.
Patients found to have significant intragraft deterioration at thrombectomy undergo insertion of a new nonanastamosed
graft parallel to the existing graft. At the next failure of the existing graft, the nonanastamosed segment is anastamosed
and used immediately for dialysis, obviating the need for a temporary catheter. Thirty patients have undergone this
technique, and 89% of those who returned to surgery have had successful anastamosis of their new segments. Two patients
were found to have inadequate incorporation of their new segments into the subcutaneous tissue, and one became frankly
infected. (J Vasc Surg 2002;35:1013-5.)
Improvements in the life expectancy of patients with
end-stage renal disease have been associated with increases
in the cost and morbidity rate associated with the mainte-
nance of hemodialysis access.1-3 A significant number of
patients now need secondary access procedures, and loss of
viable access sites has become a life-threatening problem.1,2
A contribution to this dilemma is the frequent use of
temporary percutaneous hemodialysis catheters. A signifi-
cant incidence rate of central vein stenosis and occlusion
that lead to the loss of the ipsilateral extremity as a hemo-
dialysis access site is associated with the use of these cathe-
ters.4 We present a novel surgical technique designed to
eliminate the interval from failure of permanent access to
establishment of a subsequent permanent access. This tech-
nique reduces the need for temporary catheters and main-
tains the same extremity as the site of access.
METHODS
Our procedure of parallel graft insertion without anas-
tamosis is performed at the time of operative or percutane-
ous thrombectomy or revision of a malfunctioning hemo-
dialysis access. Specifically, it is performed on patients with
significant intragraft deterioration (pseudointima or pseu-
doaneurysm formation) in whom adequate flow can be
reestablished. If adequate flow cannot be reestablished, a
new graft with anastamosis and a temporary access catheter
are placed.
After successful thrombectomy or percutaneous angio-
plasty or both, a new graft segment is placed parallel to the
existing graft in patients with significant intragraft deterio-
ration. Two small skin incisions are made within 2 to 3 cm
of the existing anastamoses. If an incision already exists
from the thrombectomy, it may serve as one of the two
incisions. A new polytetrafluorethylene graft (generally 8
mm) is tunneled in the subcutaneous tissue parallel to the
medial or lateral aspect of the existing graft under healthy
skin and away from any pseudoaneurysms. The ends of the
graft are not closed, and extra length is left to allow for
tailoring and creation of anastamoses at the time of estab-
lishment of graft continuity (Fig 1). The new graft segment
incorporates into the subcutaneous tissue while the patient
continues hemodialysis via the existing access.
At the time of failure of the existing arteriovenous graft,
the patient is returned to the operating room for establish-
ment of continuity of the new polytetrafluoroethylene graft
segment. The two small incisions are reopened, and the
ends of the new graft are dissected out. Embolectomy
catheters and dilators are passed through the new graft. The
graft segment often contains a small amount of serous
yellow fluid. If the old anastamoses are widely patent, the
old graft can be transected 1 to 2 cm from the old anasta-
moses and graft-to-graft anastamoses can be created (Fig
2). If one or both of the old anastamoses are sclerotic, the
new graft is anastamosed to the native vessel (Fig 3). If at
least 2 weeks have elapsed between insertion of the new
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segment and establishment of continuity, the graft may be
used for immediate hemodialysis.
CLINICAL EXPERIENCE
We have used this technique to place parallel polytetra-
fluoroethylene graft segments in 30 patients with brachio-
axillary grafts, and all attempts at parallel segment insertion
have been successful. Because most dialysis access grafts fail
from venous anastamotic stenosis and not intragraft dete-
rioration, we were able to apply our technique to only 10%
of our patients with failed grafts. Eighty-six percent of the
parallel segments were placed lateral to the existing grafts,
and 14% were medial. Twenty-eight patients have been
returned to the operating room for reestablishment of
continuity of the new segments. Two patients received
renal allografts before reanastamosis. The mean time inter-
val from graft segment placement to establishment of con-
tinuity was 15 weeks (range, 2 to 54 weeks).
Two segments were found to be inadequately incorpo-
rated into the subcutaneous tissue and were therefore re-
moved. Cultures of the explanted graft segments did not
grow any organisms. An additional patient had a frank
infection develop, and the old graft and new segment were
completely removed. Culture of the explanted graft seg-
ment grew out Staphyloccocus aureus. These were the only
patients in whom attempted reanastamosis was not com-
pleted.
Of the patients who returned to the operating room for
anastamosis, continuity was successfully reestablished with-
out complication in 25 of 28 (89%). All of the successfully
reanastamosed grafts functioned for immediate hemodia-
lyisis, and 22 are still functioning. Three patients died from
unrelated causes with functioning grafts. All of the remain-
ing grafts continue to function and appear to be as durable
as the original grafts.
DISCUSSION
We allow a period of 2 weeks after insertion of a
polytetrafluoroethylene graft for incorporation into the
subcutaneous tissue before cannulation. Despite emphasis
on meticulous cannulation technique, we have had a signif-
icant rate of hematoma formation in grafts cannulated
earlier than 2 weeks. That expanded polytetrafluoroethyl-
ene stretch grafts have a decreased rate of hematoma for-
mation with early cannulation has been suggested, but we
have no experience with these grafts.5 If a new polytetra-
fluoroethylene hemodialysis graft is placed only at the time
of existing graft failure, a temporary hemodialysis catheter
is necessary.
Hemodialysis grafts have a period of time when mal-
function and thrombosis as a result of intragraft deteriora-
tion necessitates thrombectomy or revision or both before
Fig 1. Polytetrafluoroethylene (PTFE) segment placed in subcu-
taneous tissues parallel to preexisting hemodialysis graft. Ends are
not anastamosed.
Fig 2. Polytetrafluoroethylene (PTFE) graft segment ends anas-
tamosed to cuffs of failed hemodialysis graft.
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ultimate failure. We take advantage of the time period
between initial graft malfunction and ultimate failure with
placement of a nonanastamosed segment of polytetrafluo-
roethylene parallel to the existing graft, in anticipation of
the impending need for new access. Although we have
shown that our procedure is technically feasible, the precise
indications remain to be defined. The proactive nature of
this procedure makes the accurate and timely identification
of patients who could potentially benefit imperative. We
have focused on patients with significant intragraft deteri-
oration as determined with subjective intraoperative assess-
ment; in our experience, these are the grafts that will need
eventual replacement. We do not see any technical reason
that this technique could not be applied to failing autoge-
nous arteriovenous fistulae, but we have not yet applied it
to this patient population. Emphasis on clear communica-
tion with the dialysis nursing staff is critical to avoid cannu-
lation of the parallel graft segment. We have found that a
diagram of the configuration of the graft segments is ben-
eficial.
A further issue that remains to be resolved is why some
graft segments fail to incorporate adequately into the sub-
cutaneous tissue. In our experience, poor graft incorpora-
tion can be seen with primary graft placement and with this
new procedure. We have hypothesized that one reason for
inadequate graft incorporation may be the presence of
subclinical graft infection. We found, however, only one
instance of overt graft infection, caused by S aureus, and the
two graft segments removed because of poor incorporation
did not grow any organisms. We use perioperative antibi-
otics with gram-positive coverage during access surgery.
Other factors, such as diabetes, systemic illness, uremia, and
local tissue trauma and devascularization as a result of prior
procedures, may also play a role, but this series is too small
to make any statistically valid correlation.
In conclusion, this procedure can be performed easily
and with minimal morbidity rates. It has allowed us to
reduce the use of temporary percutaneous catheters while
maintaining the ipsilateral extremity as the site of hemodi-
alysis access in most patients. Although our results are
encouraging, questions concerning optimal patient selec-
tion, timing, and long-term patency remain.
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Fig 3. Polytetrafluoroethylene (PTFE) segment anastamosed to
native vessel because of sclerosis of failed hemodialysis graft.
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